To observe the effect of Ayurvedic medicine for the treatment of COVID-19 : A Randomized, Open Label, Parallel Efficacy, Active Control, Exploratory Clinical Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation (AYUSH 64) as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2021) vom: 24. Nov. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 15-05-2020, Last updated: 2022-11-24 |
|---|
| ICTRP ID: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
CTG00610021X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG00610021X | ||
| 003 | DE-627 | ||
| 005 | 20230425165609.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210507s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG00610021X | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)CTRI/2020/05/025214 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NIL | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a To observe the effect of Ayurvedic medicine for the treatment of COVID-19 |b A Randomized, Open Label, Parallel Efficacy, Active Control, Exploratory Clinical Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation (AYUSH 64) as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 15-05-2020, Last updated: 2022-11-24 | ||
| 650 | 4 | |a Medical Condition: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Phase: Phase 2/Phase 3 | |
| 650 | 4 | |a Recruitment Status: Completed | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2021) vom: 24. Nov. |
| 773 | 1 | 8 | |g year:2021 |g day:24 |g month:11 |
| 856 | 4 | 0 | |u http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43727 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 24 |c 11 | ||